Plasma-first: accelerating lung cancer diagnosis and molecular profiling through liquid biopsy

Plasma-first: accelerating lung cancer diagnosis and molecular profiling through liquid biopsy

Introduction: Molecular profiling of tumor tissue is the gold standard for treatment decision-making in advanced non-small cell lung cancer (NSCLC). Results may be delayed or unavailable due to insufficient tissue, prolonged wait times for biopsy, pathology assessment and testing. We piloted the use...

Full description

Bibliographic Details
Main Authors: Miguel Garcia-Pardo, Kasia Czarnecka, Jennifer H. Law, Alexandra Salvarrey, Roxanne Fernandes, Jason Fan, Lucy Corke, Thomas K. Waddell, Kazuhiro Yasufuku, Laura L. Donahoe, Andrew Pierre, Lisa W. Le, Noor Ghumman, Geoffrey Liu, Frances A. Shepherd, Penelope Bradbury, Adrian Sacher, Tracy Stockley, Prodipto Pal, Patrik Rogalla, Ming Sound Tsao, Natasha B. Leighl
Format: Article
Language:English
Published: SAGE Publishing 2022-09-01
Series:Therapeutic Advances in Medical Oncology
Online Access:https://doi.org/10.1177/17588359221126151

Internet

https://doi.org/10.1177/17588359221126151

Similar Items